Clinical variables in pharmacoepidemiology
E H Uhlenhuth1, M B Balter, G D Mellinger
1Department of Psychiatry, School of Medicine, University of New Mexico, Albuquerque 87131.
Journal of Psychiatric Research
|January 1, 1993
Summary
Psychiatric medication use is influenced by patient symptoms, not just drug effects. Understanding clinical characteristics is crucial for interpreting psychotherapeutic drug use patterns.
Area of Science:
- Psychiatry
- Pharmacoepidemiology
- Psychology
Background:
- Pharmacoepidemiology traditionally examines drug prescription and usage rates.
- Interpretations often assume psychotropic drug rates reflect reinforcing properties.
- This study investigates clinical consumer characteristics influencing psychotherapeutic drug use patterns.
Purpose of the Study:
- To analyze the impact of consumer clinical characteristics on psychotherapeutic drug use.
- To determine if prevalence and duration of use alone sufficiently explain drug consumption patterns.
- To highlight the importance of clinical variables in understanding psychotherapeutic agent usage.
Main Methods:
- Utilized a 1979 nationwide US probability sample of 3,161 individuals (aged 18-79).
- Assessed drug consumption using one-year prevalence rates and longest period of regular daily use.
- Measured clinical characteristics via a 43-item psychological symptom checklist, quantifying psychic distress and classifying syndromes (e.g., depression, anxiety, phobias).
Main Results:
- Anxiolytics and antidepressants exhibit distinct prevalence and duration patterns.
- User clinical characteristics, including symptom severity and patterns, significantly shape these drug use patterns.
- Prevalence and duration data alone are insufficient to understand the social functions or guide medical decisions regarding these drugs.
Conclusions:
- Clinical variables are major determinants of psychotherapeutic drug consumption.
- Analysis and interpretation of psychotherapeutic drug use must incorporate user clinical information.
- A comprehensive understanding requires integrating symptom data with drug usage patterns.
More Related Videos
07:02A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
Published on: February 11, 2019
08:21Intradermal Microdialysis: An Approach to Investigating Novel Mechanisms of Microvascular Dysfunction in Humans
Published on: July 21, 2023
Related Concept Videos
01:12Analysis of Population Pharmacokinetic Data
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:24Pharmacokinetic–Pharmacodynamic Relationship: Problems
The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
01:27Pharmacodynamic Models: Overview
Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
01:24Drug Toxicity: Risk factors
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
01:26Introduction to Epidemiology
Epidemiology, known as the cornerstone of public health, involves studying the distribution and determinants of health-related events in defined populations and applying these insights to control health issues. This is essential for understanding how diseases spread, identifying populations at greater risk, and implementing measures to control or prevent outbreaks. Epidemiology addresses not only infectious diseases but also non-communicable conditions like cancer and cardiovascular disease,...